Related MeSH Hierarchy (4)
Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Diabetic Angiopathies » Diabetic Foot
Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Ulcer » Leg Ulcer » Foot Ulcer » Diabetic Foot
Diseases [C] » Endocrine System Diseases [C19] » Diabetes Mellitus » Diabetes Complications » Diabetic Angiopathies » Diabetic Foot
Diseases [C] » Endocrine System Diseases [C19] » Diabetes Mellitus » Diabetes Complications » Diabetic Neuropathies » Diabetic Foot
Description
Common foot problems in persons with DIABETES MELLITUS, caused by any combination of factors such as DIABETIC NEUROPATHIES; PERIPHERAL VASCULAR DISEASES; and INFECTION. With the loss of sensation and poor circulation, injuries and infections often lead to severe foot ulceration, GANGRENE and AMPUTATION. MeSH
Hierarchy View
Phase 4 Indicated Drugs (24)
Phase 3 Indicated Drugs (27)
Phase 2 Indicated Drugs (40)
Phase 1 Indicated Drugs (7)
Other Experimental Indicated Drugs (18)
Organization Involved with Phase 4 Indications (25)
All India Institute of Medical Sciences
Amrita Institute of Medical Sciences
Associated Foot & Ankle Specialists
Clinical Alliance for Research & Education - Infectious Diseases, LLC.
Institute of Post Graduate Medical Education & Research
Integra LifeSciences Corporation
Jawaharlal Nehru Medical College
Milton S. Hershey Medical Center
Organization Involved with Phase 3 Indications (73)
Canadian Institutes of Health Research (CIHR)
Chinese University of Hong Kong
Daewoong Pharmaceutical Co. LTD.
European Egyptian Pharmaceutical Industries
Fundación Cardiovascular de Colombia
Fundación Santandereana de Diabetes y Obesidad
Instituto de Salud de Bucaramanga
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Mashhad University of Medical Sciences
Medical University of South Carolina
Novalead Pharma Private Limited
Rovi Pharmaceuticals Laboratories
Organization Involved with Phase 2 Indications (89)
A2 Healthcare Taiwan Corporation
BioMed Valley Discoveries, Inc
Centre Hospitalier Universitaire de Nīmes
Derby Hospitals NHS Foundation Trust
Eastmed Academic Clinical Trial Center, East Lynne, South Africa
Energenesis Biomedical Co., Ltd.
HealthCare Partners, Montebello, USA
Montana Hospital, Pretoria, South Africa
National Institutes of Health (NIH)
Park Medical Center, Witbank, South Africa
Organization Involved with Phase 1 Indications (22)
Organization Involved with Other Experimental Indications (26)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
